Leerink Swann Upgrades Seattle Genetics (SGEN) to Outperform
Tweet Send to a FriendGet Alerts SGEN Hot Sheet
Price: $35.73 -0.06%
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade SGEN Now!
Leerink Swann upgrades Seattle Genetics (Nasdaq: SGEN) from Market Perform to Outperform.
To see all the upgrades/downgrades on shares of SGEN, visit our Analyst Ratings page.
Shares are currently trading at $14.28, up $0.14 (+0.99%)
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
To see all the upgrades/downgrades on shares of SGEN, visit our Analyst Ratings page.
Shares are currently trading at $14.28, up $0.14 (+0.99%)
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
- Deutsche Bank Upgrades priceline.com (PCLN) to Buy
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
